beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression.
Folkmane
I
I
Department of Transplantation, Medical Academy of Latvia, Riga, Latvia.
Chapenko
S
S
Amerika
D
D
Bicans
J
J
Murovska
M
M
Rosentals
R
R
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis; D004359:Drug Therapy, Combination; D006566:Herpesviridae Infections / Q000175:diagnosis / Q000503:physiopathology*; D016199:Herpesvirus 7, Human / Q000254:growth & development* / Q000302:isolation & purification; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications / Q000821:virology; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D014775:Virus Activation
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine